Page last updated: 2024-10-27

fentanyl and Hyperlipoproteinemia

fentanyl has been researched along with Hyperlipoproteinemia in 2 studies

Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.

Research Excerpts

ExcerptRelevanceReference
"In patients with chronic renal failure, a correlation of probability P less than 0."1.26Plasma protein binding of fentanyl: the effect of hyperlipoproteinaemia and chronic renal failure. ( Bower, S, 1982)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bower, S2

Other Studies

2 other studies available for fentanyl and Hyperlipoproteinemia

ArticleYear
Plasma protein binding of fentanyl: the effect of hyperlipoproteinaemia and chronic renal failure.
    The Journal of pharmacy and pharmacology, 1982, Volume: 34, Issue:2

    Topics: Adult; Blood Proteins; Female; Fentanyl; Humans; Hyperlipoproteinemias; Kidney Failure, Chronic; Lip

1982
The uptake of fentanyl by erythrocytes.
    The Journal of pharmacy and pharmacology, 1982, Volume: 34, Issue:3

    Topics: Blood Proteins; Dialysis; Drug Interactions; Erythrocytes; Fentanyl; Hematocrit; Hemoglobins; Humans

1982